PORTLAND, Ore. (BUSINESS WIRE) Dan Snyder, MBA, local medical diagnostics corporate executive, will lead 2021 Oregon Bioscience Association (Oregon Bio)’s board of directors.With Snyder, Executive Committee members include Sandra Shotwell, Ph.D., cofounder at Elex Biotech, LLC; Tim Brown, site head and general man.
Guest columnist Dr. Michelle McMurry-Heath offers steps Biden can take for a healthy tomorrow
Dr. Michelle McMurry-Heath
President Joe Biden is acting fast to tackle the health and economic crises that greeted him on inauguration day. The first 100 days of any new presidency are critical, all the more so when facing a pandemic.
President Biden has already taken important steps, like reversing the previous administration s decision to leave the World Health Organization and rejoining the Paris Climate Accord.
At home, the president hopes to vaccinate 150 million Americans by the end of April, and the administration recently struck deals with vaccine makers to acquire an additional 200 million doses. Through these and other measures, we may finally be on track to beat Covid-19.
The delay will undoubtedly cost countless lives and risk future, potentially dangerous mutations of the Covid-19 virus. The AstraZeneca-Oxford vaccine, initial tests showed, is far less effective against the Covid-19 variant that has spread rapidly through South Africa, for example. A prolonged pandemic will also threaten to extend and exacerbate a global economic downturn.
In response, governments around the world are considering a temporary exemption to traditional intellectual property rights in order to rapidly produce coronavirus treatments at low cost, a demand intensely opposed by American lobbyists for the pharmaceutical industry.
The push by foreign governments to unilaterally set the price and pace of production of coronavirus vaccines, drug lobbyists with the Biotechnology Innovation Organization, or BIO, argued, will place “American jobs and the workers who rely on them at risk, and impede scientific advances from reaching society.”
Share this article
Share this article
SILVER SPRING, Md., March 3, 2021 /PRNewswire/ In partnership with more than 70 advocacy groups, healthcare providers, and biotech companies, the Tuberous Sclerosis Alliance (TS Alliance), an internationally recognized nonprofit that raises awareness and funds to fight the rare genetic disease tuberous sclerosis complex (TSC), recently issued a letter to the National Governors Association that calls on states to immediately prioritize Americans with life-threatening rare diseases in their COVID-19 vaccine rollouts.
In late January, President Biden announced a strategy committed to vaccine distribution for high-risk individuals, specifically those with underlying conditions, including rare diseases. However, the 25-30 million individuals in the United States with rare diseases and their caregivers have yet to be prioritized in many states. The letter has already been submitted to several states and will be presented to every state in the
TS Alliance Advocates for Prioritization of Rare Disease Patients and Caregivers for COVID-19 Vaccines prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.